Somatostatin receptor subtype 4 (SSTR4) agonists

US9789082B2 · kind B2 · utility

Assignee

• Centrexion Therapeutics Corporation · US

Inventors

• Riccardo Giovannini · Verona, IT
• Yunhai Cui · Heidelberg, DE
• Henri Doods · Warthausen, DE
• Marco Ferrara · San Donato Milanese, IT
• Stefan Just · Biberach an der Riß, DE
• Raimund Kuelzer · Mittelbiberach, DE
• Iain Lingard · Monza, IT
• Rocco Mazzaferro · San Giuliano Milanese, IT
• Klaus Rudolf · Warthausen, DE

Key dates

• Filing date: May 18, 2016
• Grant date: Oct 17, 2017
• Expiry date: May 18, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4.